NEW MJ NEWS

AbbVie to Host Second-Quarter 2021 Earnings Conference Call

AbbVie (NYSE: ABBV) will announce its second-quarter 2021 financial results on Friday, July 30, 2021, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time. It will be accessible through AbbVie’s Investor Relations website investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content:https://www.prnewswire.com/news-releases/abbvie-to-host-second-quarter-2021-earnings-conference-call-301326236.html

SOURCE AbbVie


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Reliq Health Technologies Inc. (RQHTF) Announces Strategic Alliance with iDocsWeb to Offer its iUGO Care platform

Reliq Health Technologies, Inc. Announces Strategic Alliance with iDocsWeb to Offer its…

Tilray Brands, Inc. (TLRY) Announces 420 Activations Across Canada and Unveils Celebratory Product Lineup

Tilray Brands Announces 420 Activations Across Canada and Unveils Celebratory Product Lineup…

$FWDG Sells Subsidiary HempTech Corp.

FutureWorld (FWDG) Sells Subsidiary HempTech Corp. HempTech Corp First of Many to…

$GWPH Initiates Phase 3 Pivotal Study in Tuberous Sclerosis Complex

GW Pharmaceuticals Initiates Phase 3 Pivotal Study in Tuberous Sclerosis Complex GW…